ARCHIVES

Three Nominated To ET2; NCI Seeks Clinical Applications

This article is from The Cancer Letter archive.

Vol. 17 No. 21 | May 24, 1991

Download PDF Visit The Full Archive

Related Articles

EntreMed Begins Phase I/II Trial For Endostatin.

July 27, 2001

Animas As Early Warning “Sentinels” Part Of DCE Study

July 31, 1987

In Brief: Susan Hubbard Names Director Of International Cancer information Center; Includeds ICRDB, PDQ

September 14, 1984

Abstracts Of ‘Most Newsworthy’ Papers

June 10, 1977

Natcher Subcommittee Kills Recision, Save NCI $17 Million

May 2, 1980

“Perhaps the most troubling finding was a broad dissatisfaction with the general ethos within the intramural community.”

July 14, 1995